- Home
- NTB vs GRAL Comparison
NTB vs GRAL Comparison
Compare NTB & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTB
- GRAL
- Stock Information
- Founded
- NTB 1858
- GRAL 2016
- Country
- NTB Bermuda
- GRAL United States
- Employees
- NTB N/A
- GRAL N/A
- Industry
- NTB Commercial Banks
- GRAL
- Sector
- NTB Finance
- GRAL
- Exchange
- NTB Nasdaq
- GRAL NYSE
- Market Cap
- NTB 1.6B
- GRAL 877.1M
- IPO Year
- NTB 2016
- GRAL N/A
- Fundamental
- Price
- NTB $39.41
- GRAL $37.20
- Analyst Decision
- NTB Buy
- GRAL Buy
- Analyst Count
- NTB 4
- GRAL 3
- Target Price
- NTB $44.25
- GRAL $26.00
- AVG Volume (30 Days)
- NTB 185.3K
- GRAL 1.2M
- Earning Date
- NTB 04-23-2025
- GRAL 05-15-2025
- Dividend Yield
- NTB 4.47%
- GRAL N/A
- EPS Growth
- NTB 7.68
- GRAL N/A
- EPS
- NTB 4.81
- GRAL N/A
- Revenue
- NTB $585,277,000.00
- GRAL $125,595,000.00
- Revenue This Year
- NTB N/A
- GRAL $24.65
- Revenue Next Year
- NTB $0.79
- GRAL $12.88
- P/E Ratio
- NTB $8.19
- GRAL N/A
- Revenue Growth
- NTB 1.89
- GRAL 34.90
- 52 Week Low
- NTB $32.78
- GRAL $12.33
- 52 Week High
- NTB $41.88
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- NTB 62.04
- GRAL N/A
- Support Level
- NTB $36.81
- GRAL N/A
- Resistance Level
- NTB $40.18
- GRAL N/A
- Average True Range (ATR)
- NTB 1.32
- GRAL 0.00
- MACD
- NTB 0.32
- GRAL 0.00
- Stochastic Oscillator
- NTB 85.54
- GRAL 0.00
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.